Mylan Announces Final FDA Approval For Finasteride Tablets USP, 5mg

Mylan Laboratories Inc.
(NYSE: MYL) mean solar day announced that Mylan Pharmaceuticals Inc. has received examination commendation from the U.S.
Food and Drug Organisation (FDA) for its Abbreviated New Drug Elbow grease (ANDA) for Finasteride Tablets USP, 5mg.

The Mylan kind of Finasteride Tablets, a product written material of Merck's Proscar(R) Tablets, is approved for the intervention of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate to improve symptoms and reduce the risk of the need for operating theater including transurethral resection of the prostate and prostatectomy.
Unit U.S. sales for the 5mg strong suit of Finasteride Tablets was approximately $553 one thousand thousand for the 12-month emission ended Sept. 30, 2006, according to data from IMS Eudaimonia.

This good will be shipped immediately.

Mylan Laboratories Inc. is a lead pharmaceutical full complement with trio actor subsidiaries: Mylan Pharmaceuticals Inc., Mylan Technologies Inc. and UDL Laboratories Inc.
This is a part of article Mylan Announces Final FDA Approval For Finasteride Tablets USP, 5mg Taken from "Buy Propecia Finasteride" Information Blog